# Eradication rates of clarithromycin‐resistant <scp>Helicobacter pylori</scp> using either rabeprazole or lansoprazole plus amoxicillin and clarithromycin

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/eradication-rates-of-clarithromycin-resistant-scp-helicobacter-pylori-scp-using/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Kazunari Murakami,Reo Sato,Tadayoshi Okimoto,Masaru Nasu,Toshiyuki Fujioka,Masaaki Kodama,Jiro Kagawa,Shunzo Sato,Hiroaki Abe,Tsuyoshi Arita |
| Citations | 88 |
| DOI | 10.1046/j.1365-2036.2002.01368.x |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2036.2002.01368.x |
| OpenAlex ID | https://openalex.org/W1979341204 |
| PMID | 12390102 |
| Type | article |
| Year | 2002 |

## Paper authors

- [Masaaki Kodama](https://scholariq.org/researchers/masaaki-kodama/)

## Paper journal

- [Alimentary Pharmacology & Therapeutics](https://scholariq.org/journals/alimentary-pharmacology-and-therapeutics/)

## Paper primary topic

- [Helicobacter pylori-related gastroenterology studies](https://scholariq.org/topics/helicobacter-pylori-related-gastroenterology-studies/)

## Paper topics

- [Helicobacter pylori-related gastroenterology studies](https://scholariq.org/topics/helicobacter-pylori-related-gastroenterology-studies/)
- [Clostridium difficile and Clostridium perfringens research](https://scholariq.org/topics/clostridium-difficile-and-clostridium-perfringens-research/)
- [Pneumonia and Respiratory Infections](https://scholariq.org/topics/pneumonia-and-respiratory-infections/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.